Medicared For All Logo

Mark Ngo MD in El Segundo, California

Home California El Segundo

Mark Ngo MD has Hematology/oncology as his primary medical specialty. Their primary office is: 390 N Pacific Coast Hwy in El Segundo, California.

They're a part of the: California Hematology Oncology Medical Group medical group which has around 5 members. You can call their office at 310-649-7222 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mark Ngo MD Office Phone and Directions

Mark Ngo MD
California Hematology Oncology Medical Group
390 N Pacific Coast Hwy
El Segundo, California 90245
310-649-7222


Patient Ratings
Please rate your experience with Mark Ngo MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 310-649-7222


Enter a starting address:


Healthcare Info for Mark Ngo MD

Additional Medical Specialties Include:
MEDICAL ONCOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1999
The Primary Medical Specialty for Mark Ngo MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 6800820655
NPI #: 1982623468
NPI Created On: 07/18/2006
NPI Last Updated Listed as: 02/20/2010
Primary Taxonomy Code: 207RH0003X
License Number:
A73755
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Vietnamese, Spanish, French.


Services and Procedures include:

  1. Collection of blood specimen from central or peripheral venous catheter
  2. Blood test, comprehensive group of blood chemicals
  3. Vitamin d-3 level
  4. Carcinoembryonic antigen (cea) protein level
  5. Cyanocobalamin (vitamin b-12) level
  6. Ferritin (blood protein) level
  7. Folic acid level
  8. Iron level
  9. Iron binding capacity
  10. Lactate dehydrogenase (enzyme) level
  11. Magnesium level
  12. Phosphate level
  13. Chemical receptor analysis
  14. Uric acid level, blood
  15. Complete blood cell count (red cells, white blood cell, platelets), automated test
  16. Blood test, clotting time
  17. Immunologic analysis for detection of tumor antigen
  18. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  19. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  20. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788888669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788888671

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013495

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013493

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818600869

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $100

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Payment was made by a third party for participation in a market research study on behalf of GSK.

Record ID:: 802873601

Being Disputed:: No

Product Related: No


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832147533

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832147527

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832147659

Being Disputed:: No

Product Related: No


Payments Total: $21

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783675391

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: Pomalyst

Open Associated Drug #1: 59572-502-00


Hematology/oncology Professionals in El Segundo

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

2040 E Mariposa Ave
El-segundo, CA
Immuno-oncology Clinic Inc.

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

Providers in California Hematology Oncology Medical Group

1.Alex Makalinao

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

2.Frank Mori

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

3.Mark Ngo Md

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

4.Wade Nishimoto

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

5.Xiuqing Ru Md

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

View all 5 members of California Hematology Oncology Medical Group medical group